MEDP - Medpace Holdings, Inc.
IEX Last Trade
342.1
0.900 0.263%
Share volume: 7,609
Last Updated: Thu 26 Dec 2024 08:30:05 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
1.30%
PREVIOUS CLOSE
CHG
CHG%
$341.20
0.90
0.26%
Fundamental analysis
73%
Profitability
87%
Dept financing
27%
Liquidity
51%
Performance
75%
Performance
5 Days
1.07%
1 Month
2.23%
3 Months
5.04%
6 Months
-15.45%
1 Year
9.60%
2 Year
64.38%
Key data
Stock price
$342.10
DAY RANGE
$339.32 - $342.78
52 WEEK RANGE
$286.70 - $459.77
52 WEEK CHANGE
$10.32
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
10/21/2024
Company detail
CEO: August J. Troendle
Region: US
Website: medpace.com
Employees: 5,200
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: medpace.com
Employees: 5,200
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company was founded in 1992 and is based in Cincinnati, Ohio.
Recent news